Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria

Erratum: A role for mitochondria in NLRP3 inflammasome activation

(2011) Rongbin Zhou et al.   NATURE

Glycosylation of the OCTN2 carnitine transporter: Study of natural mutations identified in patients with primary carnitine deficiency

(2010) Cristina Amat di San Filippo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The causes of cancer revisited: “Mitochondrial malignancy” and ROS-induced oncogenic transformation – Why mitochondria are targets for cancer therapy

(2010) Stephen J. Ralph et al.   MOLECULAR ASPECTS OF MEDICINE

Multiple pathways are involved in drug resistance to doxorubicin in an osteosarcoma cell line

(2009) Thangarajan Rajkumar et al.   ANTI-CANCER DRUGS

Mitochondrial ABC proteins in health and disease

(2009) Ariane Zutz et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen

(2009) Paul Ruff et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Mrp1 Localization and Function in Cardiac Mitochondria after Doxorubicin

(2009) P. Jungsuwadee et al.   MOLECULAR PHARMACOLOGY

Resistance mechanisms to cancer chemotherapy

(2008) Kelly Marie Redmond   Frontiers in Bioscience-Landmark

Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer

(2008) Catherine Lhommé et al.   JOURNAL OF CLINICAL ONCOLOGY

Human DNA2 Is a Mitochondrial Nuclease/Helicase for Efficient Processing of DNA Replication and Repair Intermediates

(2008) Li Zheng et al.   MOLECULAR CELL

Assessment of Golgi Apparatus versus Plasma Membrane-Localized Multi-Drug Resistance-Associated Protein 1

(2008) Allyn M. Kaufmann et al.   MOLECULAR PHARMACEUTICS